Bioventus
BVS
45 hedge funds and large institutions have $334M invested in Bioventus in 2021 Q1 according to their latest regulatory filings, with 45 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EWM
Essex Woodlands Management
The Woodlands,
Texas
|
+$172M |
| 2 |
Millennium Management
New York
|
+$30.8M |
| 3 |
RG
Redmile Group
San Francisco,
California
|
+$21.4M |
| 4 |
APM
Avidity Partners Management
Dallas,
Texas
|
+$17.9M |
| 5 |
DM
Deerfield Management
New York
|
+$13.6M |
Top Sellers
BVS Hedge Fund Activity: Q1 2021 in Review
45 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Bioventus (BVS) for Q1 2021, worth a combined $334M.
Buyers outnumbered sellers: 45 funds opened new BVS positions and 0 closed out — a net gain of 45 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Essex Woodlands Management, opening a new position worth an estimated $172M.
- 45 institutional investors held Bioventus (BVS) as of Q1 2021, up from 0 in Q4 2020.
- Funds reported $334M of Bioventus stock for Q1 2021.
- 45 funds opened new Bioventus positions in Q1 2021 and 0 closed out, a net change of +45 holders.
- The largest Bioventus buyer in Q1 2021 was Essex Woodlands Management, an estimated $172M added.
Based on aggregated 13F filings for Q1 2021.